Literature DB >> 17694069

Lsm proteins bind and stabilize RNAs containing 5' poly(A) tracts.

Naomi Bergman1, Karen C M Moraes, John R Anderson, Bozidarka Zaric, Christian Kambach, Robert J Schneider, Carol J Wilusz, Jeffrey Wilusz.   

Abstract

Many orthopoxvirus messenger RNAs have an unusual nontemplated poly(A) tract of 5 to 40 residues at the 5' end. The precise function of this feature is unknown. Here we show that 5' poly(A) tracts are able to repress RNA decay by inhibiting 3'-to-5' exonucleases as well as decapping of RNA substrates. UV cross-linking analysis demonstrated that the Lsm complex associates with the 5' poly(A) tract. Furthermore, recombinant Lsm1-7 complex specifically binds 5' poly(A) tracts 10 to 21 nucleotides in length, consistent with the length of 5' poly(A) required for stabilization. Knockdown of Lsm1 abrogates RNA stabilization by the 5' poly(A) tract. We propose that the Lsm complex simultaneously binds the 3' and 5' ends of these unusual messenger RNAs and thereby prevents 3'-to-5' decay. The implications of this phenomenon for cellular mRNA decay are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17694069     DOI: 10.1038/nsmb1287

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  22 in total

Review 1.  RNA recognition by 3'-to-5' exonucleases: the substrate perspective.

Authors:  Hend Ibrahim; Jeffrey Wilusz; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2007-12-03

Review 2.  Evolutionary diversification of the Sm family of RNA-associated proteins.

Authors:  Douglas G Scofield; Michael Lynch
Journal:  Mol Biol Evol       Date:  2008-08-07       Impact factor: 16.240

Review 3.  mRNA-based therapeutics--developing a new class of drugs.

Authors:  Ugur Sahin; Katalin Karikó; Özlem Türeci
Journal:  Nat Rev Drug Discov       Date:  2014-09-19       Impact factor: 84.694

4.  LSm1-7 complexes bind to specific sites in viral RNA genomes and regulate their translation and replication.

Authors:  Rui Pedro Galão; Ashwin Chari; Isabel Alves-Rodrigues; Daniela Lobão; Antonio Mas; Christian Kambach; Utz Fischer; Juana Díez
Journal:  RNA       Date:  2010-02-24       Impact factor: 4.942

Review 5.  Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.

Authors:  Itishri Sahu; A K M Ashiqul Haque; Brian Weidensee; Petra Weinmann; Michael S D Kormann
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

Review 6.  CRISPR-derived genome editing therapies: Progress from bench to bedside.

Authors:  Holly A Rees; Alex C Minella; Cameron A Burnett; Alexis C Komor; Nicole M Gaudelli
Journal:  Mol Ther       Date:  2021-10-05       Impact factor: 11.454

7.  Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates.

Authors:  Nicoletta Scheller; Leonardo Bruno Mina; Rui Pedro Galão; Ashwin Chari; Mireia Giménez-Barcons; Amine Noueiry; Utz Fischer; Andreas Meyerhans; Juana Díez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-23       Impact factor: 11.205

Review 8.  Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Authors:  Arthur H M Burghes; Christine E Beattie
Journal:  Nat Rev Neurosci       Date:  2009-07-08       Impact factor: 34.870

Review 9.  Interplay between viruses and host mRNA degradation.

Authors:  Krishna Narayanan; Shinji Makino
Journal:  Biochim Biophys Acta       Date:  2012-12-26

Review 10.  P bodies, stress granules, and viral life cycles.

Authors:  Carla J Beckham; Roy Parker
Journal:  Cell Host Microbe       Date:  2008-04-17       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.